Demo
Close Language Tab
Locate us
Languages
B
Beryl Drugs Ltd Pharmaceuticals
(%)
  • NSE
  • BSE

Overview

  • BSE Code 524606
  • NSE Symbol
  • ISIN Demat INE415H01017
  • Book Value (₹) 18.70
  • Face Value (₹) 10.00
  • Market Cap (₹ Cr.) 10.52
  • P/E (TTM) 18.20
  • EPS (TTM) 1.14
  • Div Yield (%) 0.00

Performance

Today’s Low
Today’s High

52W Low
52W High

Open
Prev. Close
Volume

About Beryl Drugs Ltd

Beryl Drugs Ltd is engaged in the manufacture, sale, and export of branded, generic pharmaceutical formulations in India and internationally. It offers I.V.fluids, and a range of small and large volume injectables. The company also delivers comprehensive solutions in a range of eye/ear drops, veterinary products, and injections. It sells its products through its sales and distribution network. In addition, the company offers research and development, as well as contract manufacturing services. Beryl Drugs Ltd. is based in Indore, India.

Beryl Drugs Ltd was formally created and deployed as a legal entity as a public limited company on August 24, 1993. The company has taken over the running business of M/s Flora and Fauna Remedies on December 15, 1993. The shares of Beryl Drugs were listed on M.P. Stock Exchange, Bombay Stock Exchange and Ahmedabad Stock Exchange.

Beryl has emerged into a global network of pharmaceutical manufacturing, research and development, contract manufacturing services and veterinary products.

The manufacturing facilities of the company are in compliance with WHO GMP specifications.

The company owns brands like BERI-CEF injection, F-Neuron, Amplicillin INJ, P-Mol, Biprox, B-Flox and many more.

The company has received ISO 9001:2000 certification for its quality management.

Founded: 1993
Chairman: Sudhir Sethi
Managing Director: Sanjay Sethi
Address: 133 Kanchan Bag, Indore, Madhya Pradesh, 452001,